Back
Magic Software Enterprises Vs. Kymera Therapeutics Industry Stock Comparison
Buy
55
MGIC
Magic Software Enterprises
Last Price:
10.41
Seasonality Move:
7.36%
Buy
67
KYMR
Kymera Therapeutics
Last Price:
43.81
Seasonality Move:
-6.51%
Buy
55
Magic Software Enterprises (MGIC)
is a Buy
Is Magic Software Enterprises a Buy, Sell or Hold?
- The current Magic Software Enterprises [MGIC] share price is $10.41. The Score for MGIC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- MGIC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $43.80. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MGIC Stock Price Chart
What is Magic Software Enterprises's stock price today?
-
The Magic Software Enterprises share price today is $10.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGIC is experiencing slight selling pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $43.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
MGIC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 47.47 | Sell |
| Chaikin Money Flow: | -2062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.17 - 11.35) | Sell |
| Bollinger Bands (100): | (10.31 - 11.85) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.08 | Buy |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | -25430 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.48 - 45.3) | Buy |
| Bollinger Bands (100): | (32.4 - 41.52) | Buy |
MGIC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.26 | Buy |
| 20-day SMA: | 10.68 | Sell |
| 50-day SMA: | 10.56 | Sell |
| 200-day SMA: | 10.62 | Sell |
| 8-day EMA: | 10.33 | Buy |
| 20-day EMA: | 10.48 | Sell |
| 50-day EMA: | 10.67 | Sell |
| 200-day EMA: | 11.08 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 42.47 | Buy |
| 20-day SMA: | 42.87 | Buy |
| 50-day SMA: | 38.23 | Buy |
| 200-day SMA: | 33.07 | Buy |
| 8-day EMA: | 42.93 | Buy |
| 20-day EMA: | 42.2 | Buy |
| 50-day EMA: | 39.81 | Buy |
| 200-day EMA: | 34.21 | Buy |
Magic Software Enterprises Earnings Growth & MGIC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.01 per share, an increase this year of $0.04 per share, and an increase next year of $0.05 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.38 per share.
Magic Software Enterprises Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||